| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,804 |
4,453 |
$617K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,633 |
4,356 |
$405K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,967 |
1,735 |
$192K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,932 |
3,232 |
$127K |
| 99051 |
|
4,444 |
3,217 |
$71K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,240 |
2,437 |
$68K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,163 |
712 |
$50K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
992 |
462 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
785 |
683 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
118 |
44 |
$4K |
| 99070 |
|
446 |
355 |
$4K |
| 87428 |
|
26 |
12 |
$890.26 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
21 |
16 |
$574.56 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
35 |
26 |
$533.57 |
| 81003 |
|
248 |
204 |
$445.34 |
| 81025 |
|
29 |
24 |
$171.60 |
| 36415 |
Collection of venous blood by venipuncture |
13 |
12 |
$16.20 |
| 99072 |
|
1,135 |
543 |
$0.17 |
| 99000 |
|
374 |
301 |
$0.00 |